US5961982A
(en)
*
|
1985-09-06 |
1999-10-05 |
Syntro Corporation |
Recombinant herpesvirus of turkeys and uses thereof
|
US5928648A
(en)
*
|
1985-09-06 |
1999-07-27 |
Syntro Corporation |
Recombinant herpesvirus of turkeys and uses thereof
|
US5965138A
(en)
|
1985-09-06 |
1999-10-12 |
Syntro Corporation |
Recombinant chimeric virus and uses thereof
|
WO1990002802A2
(en)
*
|
1988-09-13 |
1990-03-22 |
Institute For Animal Health Limited |
Viral nucleotide sequences
|
FR2693472B1
(fr)
*
|
1992-06-26 |
1994-12-23 |
Rhone Merieux |
Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
|
FR2659349B1
(fr)
*
|
1990-03-12 |
1993-12-24 |
Rhone Merieux |
Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus.
|
EP0473210B1
(de)
*
|
1990-07-30 |
1994-04-13 |
Akzo Nobel N.V. |
Rekombinantes Mareks-Krankheitsvirus
|
FR2666589B1
(fr)
*
|
1990-09-07 |
1994-08-05 |
Rhone Merieux |
Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
|
ZA918426B
(en)
*
|
1990-10-31 |
1992-12-30 |
Akzo Nv |
Chicken anemia virus vaccine and diagnostic
|
DE4110962A1
(de)
*
|
1991-04-05 |
1992-10-08 |
Bayer Ag |
Equine herpesviren (ehv), die fremd-dna enthalten, verfahren zu ihrer herstellung und ihre verwendung in impfstoffen
|
AU657144B2
(en)
*
|
1991-07-09 |
1995-03-02 |
Juridical Foundation The Chemo-Sero-Therapeutic Research Institute |
Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
|
US5853733A
(en)
*
|
1993-02-26 |
1998-12-29 |
Syntro Corporation |
Recombinant herpesvirus of turkeys and uses thereof
|
US6913751B2
(en)
|
1992-06-12 |
2005-07-05 |
Schering-Plough Veterinary Corporation |
Recombinant avian herpesvirus useful in vaccine production
|
EP0606452B1
(de)
|
1992-07-30 |
2002-11-13 |
Akzo Nobel N.V. |
Impfstoff-vektoren von rekombinantem katzen-herpesvirus
|
US5403582A
(en)
*
|
1993-01-21 |
1995-04-04 |
Nippon Zeon Co., Ltd. |
Vaccine comprising fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus
|
EP0609739A1
(de)
*
|
1993-02-02 |
1994-08-10 |
American Cyanamid Company |
Methode der Umkehrung der Immunsuppression in Vakzinen
|
US6984728B2
(en)
|
1993-09-24 |
2006-01-10 |
Schering Corporation |
Recombinant infectious laryngotracheitis virus and uses thereof
|
WO1995018860A1
(en)
*
|
1994-01-11 |
1995-07-13 |
Cornell Research Foundation, Inc. |
Control of marek's disease by the inhibition of latency and tumor cell development
|
WO1995021255A1
(en)
*
|
1994-02-07 |
1995-08-10 |
Cornell Research Foundation, Inc. |
Compositions useful in controlling marek's disease
|
FR2719056B1
(fr)
*
|
1994-04-20 |
1996-09-06 |
Rhone Merieux |
Herpesvirus transformés pour exprimer gD in vitro.
|
US5833980A
(en)
*
|
1995-10-27 |
1998-11-10 |
Board Of Trustess Operating Michigan State University |
Sustainable cell line for the production of the Marek's disease vaccines
|
US6048535A
(en)
*
|
1997-06-12 |
2000-04-11 |
Regents Of The University Of Minnesota |
Multivalent in ovo avian vaccine
|
EP1026246B1
(de)
*
|
1997-10-03 |
2006-11-29 |
Zeon Corporation |
Rekombinanten des infektiösen vogel-herpesvirus und rekombinante impfstoffe, die unter dessen verwendung hergestellt wurden
|
CA2792479A1
(en)
|
1998-02-27 |
1999-09-02 |
The Trustees Of The University Of Pennsylvania |
Vaccines, immunotherapeutics and methods for using the same
|
CN1120238C
(zh)
*
|
1998-05-04 |
2003-09-03 |
本元正阳基因技术股份有限公司 |
以粘粒为基础构建重组单纯疱疹病毒及其用途
|
EP1038952A3
(de)
|
1998-12-09 |
2001-06-27 |
Pfizer Products Inc. |
Verfahren zur Herstellung von Mareks Disease Virus (MDV) unter Verwendung von kontinuierlichen Vogelzellinien
|
BR0008645A
(pt)
|
1999-03-03 |
2002-01-22 |
Univ Pennsylvania |
Métodos de induzir uma resposta imunológica contra um imunógeno em um indivìduo, de reduzir rejeição de células, tecido ou órgão doadores nã0-assemelhados em um indivìduo e uma resposta imunológica dominante em um indivìduo e de expandir uma subpopulação de células t associadas com uma resposta imunológica especìfica, plasmìdeo, e, composição
|
WO2000066162A1
(en)
|
1999-04-30 |
2000-11-09 |
The Trustees Of The University Of Pennsylvania |
Mutant human cd80 and compositions for and methods of making and using the same
|
AU6698900A
(en)
*
|
1999-07-16 |
2001-02-05 |
Agricultural Research Service |
Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector
|
AU2001283493B2
(en)
*
|
2000-07-14 |
2006-11-30 |
The Trustees Of The University Of Pennsylvania |
DNA vaccines encoding HIV accessory proteins
|
CA2425152A1
(en)
*
|
2000-10-04 |
2002-04-11 |
The Trustees Of The University Of Pennsylvania |
Highly expressible genes
|
AR031405A1
(es)
*
|
2000-11-21 |
2003-09-24 |
Wyeth Corp |
Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
|
US7314715B2
(en)
|
2001-06-14 |
2008-01-01 |
Schering-Plough Animal Health Corporation |
Recombinant avian herpesvirus useful in vaccine production
|
EP1633372B1
(de)
|
2003-06-13 |
2011-11-30 |
The Trustees of The University of Pennsylvania |
Vakzine, immuntherapeutika und verfahren zu ihrer verwendung
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
US20080274140A1
(en)
*
|
2004-11-19 |
2008-11-06 |
David B Weiner |
Vaccines and Methods for Using the Same
|
ATE533782T1
(de)
|
2006-01-13 |
2011-12-15 |
Univ Pennsylvania |
Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
EP2049559B1
(de)
|
2006-07-28 |
2012-12-19 |
The Trustees of the University of Pennsylvania |
Verbesserte hpv-impfstoffe
|
CN102016023A
(zh)
|
2008-04-04 |
2011-04-13 |
宾夕法尼亚州立大学托管会 |
使用il-28和组合物的疫苗和免疫治疗及其使用方法
|
KR101589511B1
(ko)
*
|
2008-04-04 |
2016-02-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
치쿤구니야 바이러스 단백질의 공통 서열, 이를 인코딩하는 핵산 분자, 조성물 및 이를 이용하는 방법
|
BRPI0913216A2
(pt)
*
|
2008-06-23 |
2016-01-19 |
Intervet Int Bv |
uso de um herpesvírus recombinante de perus, e, herpesvírus recombinante de perus.
|
US8921536B2
(en)
|
2008-10-29 |
2014-12-30 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
US8829174B2
(en)
|
2008-10-29 |
2014-09-09 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
US9050287B2
(en)
|
2009-01-23 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Vaccines for human papilloma virus and methods for using the same
|
CA2653478A1
(en)
|
2009-01-23 |
2010-07-23 |
Gregg Martin |
Automated wash system for industrial vehicles
|
KR20120093163A
(ko)
|
2009-09-14 |
2012-08-22 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Il-15 수용체 알파 및/또는 이를 인코딩하는 핵산 분자를 포함하는 백신 및 면역 치료제, 및 이를 이용하는 방법
|
CN106987595B
(zh)
|
2009-11-02 |
2021-07-06 |
宾夕法尼亚大学托管会 |
口蹄疫病毒病毒(fmdv)共有蛋白质、其编码序列及由其制备的疫苗
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
KR101784177B1
(ko)
|
2010-02-08 |
2017-10-11 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
Rantes를 암호화하는 핵산 분자, 그리고 이를 포함하는 조성물 및 이의 사용 방법
|
HUE033739T2
(en)
|
2010-10-18 |
2018-01-29 |
Intervet Int Bv |
Turkey herpesvirus vector vaccine against avian influenza in poultry
|
KR102131276B1
(ko)
|
2010-11-12 |
2020-07-08 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
공통 전립선 항원, 이것을 암호화하는 핵산 분자, 그리고 이것을 포함하는 백신 및 용도
|
JP6099573B2
(ja)
|
2011-01-31 |
2017-03-22 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
新規なヘルペス抗原をコードする核酸分子、それを含むワクチン及びその使用方法
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
MX343830B
(es)
|
2011-02-11 |
2016-11-24 |
Univ Pennsylvania |
Molecula de acido nucleico que codifica la proteina nuclear del virus de la hepatitis b y vacuna que comprende la misma.
|
WO2012117045A1
(en)
|
2011-03-02 |
2012-09-07 |
Intervet International B.V. |
Infectious bronchitis virus (ibv) spike protein as subunit vaccine
|
KR102071228B1
(ko)
|
2011-07-11 |
2020-01-30 |
이노비오 파마수티컬즈, 인크. |
교차-보호성 아레나바이러스 백신 및 이의 사용 방법
|
KR20140076613A
(ko)
|
2011-10-12 |
2014-06-20 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법
|
US8932604B2
(en)
*
|
2011-10-21 |
2015-01-13 |
Intervet Inc. |
Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
|
RU2593950C2
(ru)
|
2011-10-21 |
2016-08-10 |
Интервет Интернэшнл Б.В. |
Рекомбинантный непатогенный mdv-вектор, обеспечивающий полиспецифический иммунитет
|
WO2013062507A1
(en)
|
2011-10-24 |
2013-05-02 |
The Trustees Of The University Of Pennsylvania |
Improved hcv vaccines and methods for using the same
|
US9114108B2
(en)
|
2011-11-30 |
2015-08-25 |
Merial, Inc. |
Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
|
ES2775218T3
(es)
|
2011-11-30 |
2020-07-24 |
Boehringer Ingelheim Animal Health Usa Inc |
Vectores HVT recombinantes que expresan antígenos de patógenos aviares y usos de los mismos
|
US9101598B2
(en)
|
2011-11-30 |
2015-08-11 |
Merial, Inc. |
Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
|
JP6407028B2
(ja)
|
2011-12-12 |
2018-10-17 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
MRSAのPBP2a及びその断片を含むタンパク質、それをコードする核酸、並びにMRSA感染を予防する及び治療するための組成物及びそれらの使用
|
US9272024B2
(en)
|
2011-12-12 |
2016-03-01 |
The Trustees Of The University Of Pennsylvania |
Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same
|
EP2644702A1
(de)
|
2012-03-30 |
2013-10-02 |
Ceva Sante Animale |
Multivalentes rekombinantes Vogelherpesvirus und Impfstoff zur Immunisierung von Vogelarten
|
WO2013155205A1
(en)
|
2012-04-10 |
2013-10-17 |
The Trustees Of The University Of Pennsylvania |
Human respiratory syncytial virus concensus antigens, nucleic acid constructs and vaccines made thereform, and methods of using same
|
WO2014165291A1
(en)
|
2013-03-12 |
2014-10-09 |
The Trustees Of The University Of Pennsylvania |
Improved vaccines for human papilloma virus and methods for using the same
|
CA2895806C
(en)
|
2013-03-15 |
2023-02-21 |
The Trustees Of The University Of Pennsylvania |
Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
|
US11419925B2
(en)
|
2013-03-15 |
2022-08-23 |
The Trustees Of The University Of Pennsylvania |
Cancer vaccines and methods of treatment using the same
|
CN104046597A
(zh)
*
|
2014-06-05 |
2014-09-17 |
北京市农林科学院 |
表达鹦鹉热衣原体pmpD-N基因的HVT重组体及其构建
|
AR103245A1
(es)
|
2014-12-24 |
2017-04-26 |
Intervet Int Bv |
Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada
|
MX2018015756A
(es)
|
2016-06-17 |
2019-05-30 |
Intervet Int Bv |
Construcciones de virus de la enfermedad de marek recombinantes no patogenicas codificadoras de antigenos del virus de la laringotraqueitis infecciosa y del virus de la enfermedad bursal infecciosa.
|
ES2936117T3
(es)
|
2016-12-14 |
2023-03-14 |
Boehringer Ingelheim Animal Health Usa Inc |
Vectores recombinantes de VHT que expresan múltiples antígenos de patógenos aviares y vacunas que los comprenden
|
EP3694987A1
(de)
|
2017-10-12 |
2020-08-19 |
Intervet International B.V. |
Rekombinante nicht-pathogene marek-krankheitsviruskonstrukte, die für mehrere heterologe antigene kodieren
|
RU2748903C1
(ru)
|
2017-12-13 |
2021-06-01 |
Иновио Фармасьютикалз, Инк. |
Противораковые вакцины, нацеленные на prame, и их применения
|
CA3084135C
(en)
|
2017-12-13 |
2024-03-05 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting muc16 and uses thereof
|
US11154602B2
(en)
|
2017-12-13 |
2021-10-26 |
Inovio Pharmaceuticals, Inc. |
Cancer vaccines targeting mesothelin and uses thereof
|
US11464849B2
(en)
|
2019-09-11 |
2022-10-11 |
Zoetis Services Llc |
Recombinant herpesvirus of turkey vectors expressing antigens of avian pathogens and uses thereof
|
CN114828882A
(zh)
|
2019-12-20 |
2022-07-29 |
英特维特国际股份有限公司 |
多价hvt载体疫苗
|
KR20230040328A
(ko)
|
2020-06-17 |
2023-03-22 |
베링거잉겔하임베트메디카게엠베하 |
인플루엔자 헤마글루티닌을 발현하는 재조합 hvt 벡터 및 면역원성 조성물, 및 이의 제조 및 용도
|
KR102432779B1
(ko)
|
2020-10-07 |
2022-08-16 |
서울과학기술대학교 산학협력단 |
일원화된 흑색 산화물 입자 합성 방법
|
US20240058436A1
(en)
|
2020-12-24 |
2024-02-22 |
Intervet Inc. |
Multivalent hvt vector vaccine
|
WO2023213946A1
(en)
|
2022-05-05 |
2023-11-09 |
Intervet International B.V. |
New multivalent hvt vector vaccine
|